Tirofiban for Successful Endovascular Stroke Thrombectomy
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 712 participants.
Also called NCT06373042
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 712 participants
- Sponsor
- Registry
-
NCT06373042
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT06373042. Randomized; quadruple masking; primary purpose treatment. Start 2024-07-31 (anticipated); primary completion 2026-07-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Tirofiban for Successful Endovascular Stroke Thrombectomy
- Acronym
- ADJUVANT-2
- Condition
- Stroke, Acute Ischemic
- Intervention (Drug)
- Intraarterial and intravenous tirofiban
- Intervention (Drug)
- Intraarterial and intravenous placebo
- Lead sponsor
- Zhongming Qiu
- Collaborator
- Mianyang Central Hospital
- Collaborator
- The Second Affiliated Hospital of Chongqing Medical University
- Collaborator
- The Second Hospital of Jiaozuo
- Collaborator
- Chongzhou People's Hospital
- Collaborator
- Xihua First Hospital
- Collaborator
- Xingguo People's Hospital
Record details
- Record id
cardio:ct-nct06373042- Content hash
61416cf821b8e8cefddbd94713f18efa8f441f7364e0277fe8a5c1b16cff3cea